This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
July 17, 2012 8:30 am ET
Michael J. Higgins - Chief Financial Officer, Chief Operating Officer, Principal Accounting Officer and Senior Vice President
Thomas A. McCourt - Chief Commercial Officer and Senior Vice President of Marketing & Sales
Mark G. Currie - Chief Scientific Officer and Senior Vice President of Research & Development
James M. DeTore - Vice President of Finance and Administration
Geoffrey C. Meacham - JP Morgan Chase & Co, Research Division
Graig Suvannavejh - Jefferies & Company, Inc., Research Division
Gregory R. Wade - Wedbush Securities Inc., Research Division
Juan F. Sanchez - Ladenburg Thalmann & Co. Inc., Research Division
Rachel L. McMinn - BofA Merrill Lynch, Research Division
Mario V. Corso - Caris & Company, Inc., Research Division
Irina Rivkind - Cantor Fitzgerald & Co., Research Division
Good day, ladies and gentlemen, and welcome to the Ironwood Pharmaceuticals Second Quarter 2012 Investor Update Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to introduce your host, Meredith Kaya. Please go ahead.
Good morning, and thank you for joining us for our second quarter 2012 investor update. Joining me for today's call is Michael Higgins, our Chief Operating Officer. We also have Peter Hecht, our Chief Executive Officer; Mark Currie, our Chief Scientific Officer; Tom McCourt, our Chief Commercial Officer; and Jim DeTore, our Vice President of Finance, available for the question-and-answer portion of the call.
By now, you should have a copy of our press release which crossed the wire earlier this morning. If you need a copy of the press release, you can go to our website, www.ironwoodpharma.com, to find an electronic copy.